Total Return chart Regeneron Pharmaceuticals, Inc.

Equities

Market Closed - Nasdaq Other stock markets 02:30:00 21/01/2026 am IST			5-day change	1st Jan Change
733.78 ^USD	+0.10%		-3.31%	-4.93%

06:50pm	Ocular Therapeutix, Inc. Appoints David W. Robinson As Global Chief Commercial Officer	CI
20/01	RBC Cuts Price Target on Regeneron Pharmaceuticals to $745 From $766, Keeps Sector Perform Rating	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.